revolade
novartis europharm limited - eltrombopag - purpura, trombocytopenická, idiopatická - other systemic hemostatics, antihemorrhagics - revolade is indicated for the treatment of adult patients with primary immune thrombocytopenia (itp) who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 a 5. revolade is indicated for the treatment of paediatric patients aged 1 year and above with primary immune thrombocytopenia (itp) lasting 6 months or longer from diagnosis and who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 a 5. revolade is indicated in adult patients with chronic hepatitis c virus (hcv) infection for the treatment of thrombocytopenia, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy (see sections 4. 4 and 5. revolade is indicated in adult patients with acquired severe aplastic anaemia (saa) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable for haematopoietic stem cell transplantation (see section 5.
belusha
gedeon richter plc., maďarsko - drospirenón a etinylestradiol - 17 - anticoncipientia
perlinring
actavis group ptc ehf., island - vaginálne krúžky s progestínom a estrogénom - 17 - anticoncipientia
angiletta 2 mg / 0,03 mg
actavis group ptc ehf., island - chlórmadinón a etinylestradiol - 17 - anticoncipientia
kostya 0,02 mg/0,075 mg obalené tablety
gedeon richter plc., maďarsko - gestodén a etinylestradiol - 17 - anticoncipientia
zulfija 0,03 mg/0,075 mg obalené tablety
gedeon richter plc., maďarsko - gestodén a etinylestradiol - 17 - anticoncipientia
werrca
gedeon richter plc., maďarsko - drospirenón a etinylestradiol - 17 - anticoncipientia
kirga
gedeon richter plc., maďarsko - drospirenón a etinylestradiol - 17 - anticoncipientia
aranesp
amgen europe b.v. - darbepoetínu alfa - anemia; cancer; kidney failure, chronic - iné prípravky protianemický - liečba symptomatickej anémie spojenej s chronickým zlyhaním obličiek (crf) u dospelých a detských pacientov. liečbu symptomatických anémia u dospelých pacientov s rakovinou s non-myeloidná malignancies dostávajú chemoterapiu.
biopoin
teva gmbh - epoetínu theta - kidney failure, chronic; anemia; cancer - iné prípravky protianemický - liečba symptomatickej anémie spojenej s chronickým zlyhaním obličiek u dospelých pacientov. liečbu symptomatických anémia u dospelých pacientov s rakovinou s non-myeloidná malignancies dostávajú chemoterapiu.